您的位置: 首页 > 农业专利 > 详情页

Pharmaceutical formulations of a brutons tyrosine kinase inhibitor
专利权人:
发明人:
Ching W. Chong,Robert Kuehl,Heow Tan,Harisha Atluri
申请号:
US15909779
公开号:
US10010507B1
申请日:
2018.03.01
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Described herein are pharmaceutical formulations of Brutons tyrosine kinase (Btk) inhibitor 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one. Also disclosed are methods of using the Btk inhibitor, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充